Hepatitis B Surface Antigen

ATC — · 3 markets · 10 records

Hepatitis B Surface Antigen 3 markets · 10 records Forms

SG 5 records · 3 strengths

  • 20 mcg/mLinjectionENGERIX-B SUSPENSION FOR INJECTION IN PREFILLED SYRINGE 20MCG/MLTWINRIX VACCINE
  • 0.01 mg/0.5 mLinjectionENGERIX-B SUSPENSION FOR INJECTION IN PREFILLED SYRINGE 10mcg/0.5mlINFANRIX HEXA VACCINE

Records without a stated strength · 1 HEXAXIM SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE

AU 4 records · 2 strengths

  • 0.01 mginjectionHEXAXIM DTPa-hepB-IPV-Hib Suspension for injection in pre-filled syringeVAXELIS DTPa5-HepB-IPV-Hib vaccine suspension for injection in 0.5 mL pre-filled syringe unknown

Records without a stated strength · 1 Hexaxim、Vaxelis

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

    Records without a stated strength · 1 Heplisav B

    The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

    Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

    A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.